Vibigaba (germinated brown rice) and maintenance of long-term normal blood glucose concentration: evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006

Show full item record



Permalink

http://hdl.handle.net/10138/227997

Citation

Turck , D & EFSA NDA Panel 2017 , ' Vibigaba (germinated brown rice) and maintenance of long-term normal blood glucose concentration: evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006 ' , EFSA Journal , vol. 15 , no. 7 , 4916 . https://doi.org/10.2903/j.efsa.2017.4916

Title: Vibigaba (germinated brown rice) and maintenance of long-term normal blood glucose concentration: evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006
Author: Turck, Dominique; EFSA NDA Panel
Date: 2017-07-21
Language: eng
Number of pages: 9
Belongs to series: EFSA Journal
ISSN: 2314-9396
URI: http://hdl.handle.net/10138/227997
Abstract: Following an application from Loc Troi group, submitted for authorisation of a health claim pursuant to Article 13(5) of Regulation (EC) No1924/2006 via the Competent Authority of the Netherlands, the EFSA Panelon Dietetic Products, Nutrition and Allergies (NDA) was asked to deliver an opinion on the scientific substantiation of a health claim related to Vibigaba (germinated brown rice) and maintenance of long-term normal blood glucose concentration. The scope of the application was proposed to fall under a health claim based on newly developed scientific evidence. The food proposed by the applicant as the subject of the health claim is Vibigaba. The Panelconsiders that the germinated brown rice Vibigaba is sufficiently characterised. The claimed effect proposed by the applicant is contribution to the maintenance of normal glycated haemoglobin level'. The Panelconsiders that maintenance of long-term normal blood glucose concentration is a beneficial physiological effect. The Panelnotes that the applicant did not perform a comprehensive literature search to identify human intervention studies which could be pertinent to the claim. The applicant did not reply to a specific request from EFSA to provide this information. The applicant identified one human intervention study as being pertinent to the claim. The Panelnotes the important methodological limitations of the study (e.g. statistical methods used for data analysis not appropriate for the study design) and that the information provided on the design and conduct of the study is insufficient for a complete scientific evaluation. The Panelconsiders that no conclusions can be drawn from this study for the scientific substantiation of the claim. The Panelconcludes that a cause and effect relationship has not been established between the consumption of Vibigaba (germinated brown rice) and maintenance of long-term normal blood glucose concentration.
Subject: 416 Food Science
germinated brown rice
Vibigaba
blood glucose
HbA1c
health claim
Rights:


Files in this item

Total number of downloads: Loading...

Files Size Format View
Turck_et_al_2017_EFSA20174916_Journal_3.pdf 572.9Kb PDF View/Open

This item appears in the following Collection(s)

Show full item record